<DOC>
	<DOCNO>NCT02900417</DOCNO>
	<brief_summary>The present study recruit 9 newly diagnose type 2 diabetic patient receive sitagliptin 100mg daily 12 week . The aim study investigate composition gut microbiota therapy sitagliptin .</brief_summary>
	<brief_title>Evaluation Effect Sitagliptin Gut Microbiota Patients With Newly Diagnosed Type 2 Diabetes</brief_title>
	<detailed_description>The present study include 9 newly diagnose type 2 diabetic patient receive sitagliptin 100mg daily 12 week . These patient receive 75g oral glucose tolerance test fast plasma glucose level , lipid level , fast insulin level 2 hour post-load plasma glucose level measure . Stool sample collect initiation use sitagliptin . After 12 week , patient fast plasma glucose level , lipid level , fast insulin level test . Stool sample collect .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Newlydiagnosed type 2 diabetic patient age 4070 year Any chronic disease ( diabetes ) Alcohol consumption/smoking Pregnancy/breastfeeding The use antibiotic , proprebiotics within 3 month History intestinal surgery</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>type 2 diabetes</keyword>
	<keyword>gut microbiota</keyword>
	<keyword>sitagliptin</keyword>
</DOC>